Nuvalent Future Growth
Future criteria checks 2/6
Nuvalent's earnings are forecast to decline at 1.1% per annum while its annual revenue is expected to grow at 60.5% per year. EPS is expected to grow by 1.4% per annum.
Key information
-1.1%
Earnings growth rate
1.4%
EPS growth rate
Biotechs earnings growth | 28.4% |
Revenue growth rate | 60.5% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 31 Jul 2024 |
Recent future growth updates
Recent updates
Nuvalent (NASDAQ:NUVL) Is In A Strong Position To Grow Its Business
Aug 05Nuvalent: Making Precise Progress In Its Oncology Pipeline
Jun 24Nuvalent: NVL-655 Could Bring Blockbuster Potential
Jun 14Here's Why We're Not Too Worried About Nuvalent's (NASDAQ:NUVL) Cash Burn Situation
Apr 22Nuvalent: Pivotal NSCLC Programs Progressing With Additional Data In 2024
Feb 26Is Nuvalent, Inc. (NASDAQ:NUVL) Trading At A 36% Discount?
Jan 07Companies Like Nuvalent (NASDAQ:NUVL) Can Afford To Invest In Growth
Sep 23Here's Why We're Not At All Concerned With Nuvalent's (NASDAQ:NUVL) Cash Burn Situation
Jun 10We're Interested To See How Nuvalent (NASDAQ:NUVL) Uses Its Cash Hoard To Grow
Feb 24Here's Why We're Not Too Worried About Nuvalent's (NASDAQ:NUVL) Cash Burn Situation
Sep 13Nuvalent GAAP EPS of -$0.38 beats by $0.03
Aug 10Here's Why We're Not At All Concerned With Nuvalent's (NASDAQ:NUVL) Cash Burn Situation
May 28We're Hopeful That Nuvalent (NASDAQ:NUVL) Will Use Its Cash Wisely
Oct 29Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 27 | -269 | -200 | -330 | 9 |
12/31/2025 | 7 | -237 | -188 | -217 | 11 |
12/31/2024 | N/A | -198 | -176 | -146 | 11 |
3/31/2024 | N/A | -146 | -111 | -111 | N/A |
12/31/2023 | N/A | -126 | -100 | -100 | N/A |
9/30/2023 | N/A | -114 | -87 | -87 | N/A |
6/30/2023 | N/A | -100 | -83 | -83 | N/A |
3/31/2023 | N/A | -89 | -76 | -76 | N/A |
12/31/2022 | N/A | -82 | -65 | -65 | N/A |
9/30/2022 | N/A | -73 | -60 | -60 | N/A |
6/30/2022 | N/A | -66 | -53 | -53 | N/A |
3/31/2022 | N/A | -57 | -48 | -48 | N/A |
12/31/2021 | N/A | -46 | -40 | -40 | N/A |
9/30/2021 | N/A | -36 | -32 | -32 | N/A |
6/30/2021 | N/A | -28 | -25 | -25 | N/A |
3/31/2021 | N/A | -27 | -18 | -18 | N/A |
12/31/2020 | N/A | -15 | -15 | -15 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NUVL is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: NUVL is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: NUVL is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: NUVL's revenue (60.5% per year) is forecast to grow faster than the US market (8.5% per year).
High Growth Revenue: NUVL's revenue (60.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NUVL's Return on Equity is forecast to be high in 3 years time